The Council in partnership with IPLAN and the Public Affairs Section of the US Embassy held a media parley on IP infringement in the pharma space on the 10th of December.

Stakeholders shared their perspectives and experiences on IP Infringement from a legal and media coverage point of view. Panel speakers discussed the impact of IP infringement to patient safety, the Continental free trade, protecting innovation and shared best practice on IP reporting.

This event is powered by Johnson and Johnson.